NEWS May 14, 2021

PHN Vaccines May Newsletter: COVID-19, New Product Information for VAXELIS™, and More


Read our most recent PHN Vaccines Newsletter for important vaccine updates, including new product information on VAXELIS™, and make sure to subscribe to receive announcements from the network in the future.

Dear PHN Vaccines member practices,

Spring is here. With the change in season, we are focused on supporting your practice during the transition back to more in-person events, sports, and school for the kids and families you serve. Please keep an eye out for more regular updates from us – at least quarterly – regarding the latest in vaccine products, pricing, and relevant news.

All the best,
Dr. Mark Weissman
Executive Medical Director

New Product Announcement

VAXELIS™ – the first hexavalent vaccine approved by the FDA – will be available in June 2021. A detailed fact sheet is available upon request. Prescribing information and patient information are available online.

VAXELIS™, developed in partnership between Merck & Co., Inc. and Sanofi Pasteur Inc., protects against 6 infectious agents in a single shot: Diphtheria, Tetanus, Pertussis, Polio, Hepatitis B, and Hib. VAXELIS™ helps simplify the execution of the vaccination schedule with 2-3 fewer shots and comes in a ready-to-use formulation requiring no reconstitution and will be available in prefilled syringes and vials.

  • VAXELIS™ is to be administered as a 3-dose series at 2,4, and 6 months of age. This does not include the fourth dosage of DTaP or Hib scheduled for 18 months. VAXELIS™ would be an alternative to Pentacel or Pediarix.
  • PHN Vaccines members currently enrolled in our Sanofi program will be eligible to access significant discounts through the Performance Pricing program. Members must agree to market share participation standards to receive enhanced discounts.

If you wish to benefit from the PHN Vaccines discount for VAXELIS™ or if you have additional questions, please email us at

COVID-19 Vaccination for Children and Adolescents

We continue to monitor the news related to COVID-19 vaccinations for adolescents and children. The Pfizer-BioNTech COVID-19 vaccine is now approved for Emergency Use Authorization for ages 12-15 and we expect the Moderna COVID-19 vaccine to follow shortly. We will share new resources and updates as the situation evolves.

The American Academy of Pediatrics provides resources for your ongoing preparation:

Children’s National currently offers vaccines to select groups of patients (currently DC and Prince George’s County residents only)but the guidance and regulations continue to evolve. Visit the Children’s National COVID-19 Resources website for more information. Please check with your local AAP chapter or State/local resources for the latest updates in your area.

Wellness Visits and Vaccinations in Children and Adolescents

Numerous reports have noted a drop in vaccination and prevention services during the COVID-19 pandemic. Community mitigation efforts resulted in declines in outpatient pediatric visits and fewer vaccine doses administered, leaving children and adolescents at risk for vaccine-preventable diseases.

Ongoing pandemic response could introduce complexity during the 2021 back-to-school season. Key points to consider:

  • Summer is a peak time to complete adolescent wellness visits and vaccination catch-up prior to the school year.
  • As younger populations become eligible to receive COVID-19 vaccines, thoughtful planning will be essential to ensure they also receive routinely recommended and catch-up vaccines.
  • Currently, there are no data or recommendations to support concomitant use of COVID-19 vaccine with other vaccines. As a result, COVID-19 vaccines cannot be given concurrently with others, nor can be given within 14 days of other vaccines.

Additional tips to support your ongoing efforts for adolescent catch-up can be found in the document, “The Pandemic Impact on Wellness Visits and Vaccinations for Children and Adolescents” from Merck & Co. Inc.

About PHN Vaccines

PHN Vaccines improves regional pediatric care and collaboration through group purchasing arrangements and best-in-class pricing for vaccines under our service. For more information, please visit PHN Vaccines online.